Subsequently, in the GEPIA2 database, the expression level of KIFC2 in rectal cancer (READ) was significantly lower than that of the control group, while the expression level of KIFC3 in colon cancer (COAD) was significantly higher than that of the control group (p < 0.05) (Figure 3G,H). This evidence concerns the gene KIFC3 and colon adenocarcinoma.